How does non-invasive prenatal screening (NIPT) using cell-free fetal DNA integrate into the current paradigms for screening and diagnostic testing for aneuploidy?

How does non-invasive prenatal screening (NIPT) using cell-free fetal DNA integrate into the current paradigms for screening and diagnostic testing for aneuploidy?

How does non-invasive prenatal screening (NIPT) using cell-free fetal DNA integrate into the current paradigms for screening and diagnostic testing for aneuploidy?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Mike Ruma, MD, MPH, FACOG

Mike Ruma, MD, MPH, FACOG

Maternal–Fetal Medicine Specialist
Perinatal Associates of New Mexico
Albuquerque, NM